Scarica l'app Stockscreener
9.75
2.50%
-0.24
Precedente Chiudi:
$9.99
Aprire:
$9.74
Volume 24 ore:
146.46K
Relative Volume:
0.16
Capitalizzazione di mercato:
$742.58M
Reddito:
$54.55M
Utile/perdita netta:
$-193.57M
Rapporto P/E:
-3.3737
EPS:
-2.89
Flusso di cassa netto:
$-181.86M
1 W Prestazione:
+1.88%
1M Prestazione:
-16.11%
6M Prestazione:
-55.83%
1 anno Prestazione:
-35.79%
Intervallo 1D:
$9.545
$9.86
Intervallo di 1 settimana:
$9.25
$10.14
Portata 52W:
$8.18
$29.56
Nurix Therapeutics Inc Stock (NRIX) Company Profile
Nome
Nurix Therapeutics Inc
Settore
Industria
Telefono
(415) 660-5320
Indirizzo
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
Confronta NRIX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NRIX
Nurix Therapeutics Inc
|
9.74 | 721.19M | 54.55M | -193.57M | -181.86M | -2.89 |
|
ONC
Beigene Ltd Adr
|
241.97 | 24.41B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.93 | 111.55B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.31 | 42.47M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
588.51 | 63.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
75.05 | 5.92B | 0 | -153.72M | -103.81M | -2.00 |
Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-17 | Iniziato | Leerink Partners | Market Perform |
| 2024-12-10 | Iniziato | BTIG Research | Buy |
| 2024-12-06 | Iniziato | BMO Capital Markets | Outperform |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-10-11 | Iniziato | Jefferies | Buy |
| 2024-09-06 | Ripresa | Robert W. Baird | Outperform |
| 2024-07-31 | Iniziato | Truist | Buy |
| 2023-06-26 | Ripresa | Oppenheimer | Outperform |
| 2023-03-09 | Iniziato | Barclays | Overweight |
| 2023-02-28 | Iniziato | Oppenheimer | Outperform |
| 2022-10-11 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-05-31 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-02-10 | Iniziato | Wells Fargo | Equal Weight |
| 2021-12-29 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-14 | Iniziato | SVB Leerink | Outperform |
| 2021-06-04 | Ripresa | Robert W. Baird | Outperform |
| 2021-04-30 | Ripresa | Piper Sandler | Overweight |
| 2021-04-30 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-04-14 | Iniziato | Berenberg | Buy |
| 2020-11-19 | Iniziato | Robert W. Baird | Outperform |
| 2020-08-18 | Iniziato | JP Morgan | Overweight |
| 2020-08-18 | Iniziato | Needham | Buy |
| 2020-08-18 | Iniziato | Piper Sandler | Overweight |
| 2020-08-18 | Iniziato | Stifel | Buy |
Mostra tutto
Nurix Therapeutics Inc Borsa (NRIX) Ultime notizie
Deutsche Bank AG Sells 323,485 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Soleus Capital Management L.P. Has $39.62 Million Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
97,889 Shares in Nurix Therapeutics, Inc. (NASDAQ:NRIX) Purchased by Velan Capital Investment Management LP - MarketBeat
Vestal Point Capital LP Purchases 60,000 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Northern Trust Corp Grows Stock Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Jacobs Levy Equity Management Inc. Buys Shares of 229,369 Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Point72 Asset Management L.P. Makes New $16.45 Million Investment in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics Holds 2025 Annual Stockholders Meeting - TipRanks
Nurix Therapeutics reports stockholder voting results - Investing.com
Ensign Peak Advisors Inc Acquires 194,673 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) is Patient Square Capital LP's 6th Largest Position - MarketBeat
Parkman Healthcare Partners LLC Has $10.03 Million Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Cubist Systematic Strategies LLC Acquires Shares of 124,025 Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Bought by Integral Health Asset Management LLC - MarketBeat
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listin - GuruFocus
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com
Nurix CFO and CBO to Share Latest Company Updates at Major RBC Healthcare Conference Next Week - Stock Titan
Nurix Therapeutics Announces Presentations of Clinical Data at t - GuruFocus
Nurix Therapeutics Announces Presentations of Clinical Data at the 30th European Hematology Association Congress and the 18th International Conference on Malignant Lymphoma - The Manila Times
Nurix Therapeutics to Present Phase 1a/b Clinical Trial Data on Bexobrutideg (NX-5948) for CLL and Waldenström Macroglobulinemia at EHA 2025 and 18-ICML Conferences - Nasdaq
Breakthrough Blood Cancer Treatment: Nurix's BTK Degrader Shows Promising Clinical Results in CLL Patients - Stock Titan
Where are the Opportunities in (NRIX) - news.stocktradersdaily.com
Why Nurix Therapeutics (NRIX) Is Among the Best Low Priced Biotech Stocks to Buy Now - Insider Monkey
10 Best Low Priced Biotech Stocks to Buy Now - Insider Monkey
Shareholders Will Probably Hold Off On Increasing Nurix Therapeutics, Inc.'s (NASDAQ:NRIX) CEO Compensation For The Time Being - simplywall.st
Voya Investment Management LLC Acquires 34,811 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
135,903 Shares in Nurix Therapeutics, Inc. (NASDAQ:NRIX) Purchased by First Trust Advisors LP - MarketBeat
Raymond James Financial Inc. Takes $1.03 Million Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Deep Track Capital LP Sells 868,104 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Invesco Ltd. Decreases Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Boxer Capital Management LLC Makes New Investment in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Sold by JPMorgan Chase & Co. - MarketBeat
RA Capital Management L.P. Acquires Shares of 1,333,333 Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Sold by Price T Rowe Associates Inc. MD - MarketBeat
Needham & Company LLC Reaffirms "Buy" Rating for Nurix Therapeutics (NASDAQ:NRIX) - MarketBeat
Darwin Global Management Ltd. Invests $3.08 Million in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Schonfeld Strategic Advisors LLC Boosts Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Lord Abbett & CO. LLC Boosts Stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
(NRIX) Trading Signals - news.stocktradersdaily.com
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Sold by T. Rowe Price Investment Management Inc. - MarketBeat
Nurix Therapeutics Inc Azioni (NRIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
17.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):